Therapeutic protocol for idiopathic pulmonary fibrosis

被引：0
|
作者：
Bouros, Demosthenes [1 ]
Manali, Effrosyni D. [2 ]
Papiris, Spyros A. [2 ]
Antoniou, Katerina M. [3 ]
机构：
[1] Univ Athens, Sch Med, Dept Pneumonol 1, Athens, Greece
[2] Univ Athens, Sch Med, Dept Pneumonol 2, Athens, Greece
[3] Univ Crete, Sch Med, Dept Pneumonol, Iraklion, Greece
来源：
PNEUMON | 2014年 / 27卷 / 04期
关键词：
Idiopathic Pulmonary Fibrosis; Pirfenidone; Nintedanib; Treatment;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：285 / 288
页数：4
相关论文
共 50 条
  • [1] Therapeutic targets in idiopathic pulmonary fibrosis
    Kolb, Martin
    Bonella, Francesco
    Wollin, Lutz
    RESPIRATORY MEDICINE, 2017, 131 : 49 - 57
  • [2] Therapeutic advances in idiopathic pulmonary fibrosis
    Fraser, Emily
    Hoyles, Rachel K.
    CLINICAL MEDICINE, 2016, 16 (01) : 42 - 51
  • [3] Therapeutic advances in idiopathic pulmonary fibrosis
    George, G.
    Vaid, U.
    Summer, R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 (01) : 30 - 32
  • [4] Therapeutic Update in Idiopathic Pulmonary Fibrosis
    Chan, Andrew L.
    Rafii, Rokhsara
    Louie, Samuel
    Albertson, Timothy E.
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2013, 44 (01) : 65 - 74
  • [5] Therapeutic Update in Idiopathic Pulmonary Fibrosis
    Andrew L. Chan
    Rokhsara Rafii
    Samuel Louie
    Timothy E. Albertson
    Clinical Reviews in Allergy & Immunology, 2013, 44 : 65 - 74
  • [6] Update on therapeutic management of idiopathic pulmonary fibrosis
    Tzouvelekis, Argyris
    Bonella, Francesco
    Spagnolo, Paolo
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 359 - 370
  • [7] Idiopathic pulmonary fibrosis - Pathogenesis and therapeutic concepts
    Hostettler, Katrin
    THERAPEUTISCHE UMSCHAU, 2016, 73 (01) : 19 - 24
  • [8] A NEW THERAPEUTIC APPROACH IN IDIOPATHIC PULMONARY FIBROSIS
    KEOGH, BA
    BERNARDO, J
    HUNNINGHAKE, GW
    LINE, BR
    PRICE, D
    CRYSTAL, RG
    CLINICAL RESEARCH, 1980, 28 (02): : A427 - A427
  • [9] Emerging therapeutic interventions for idiopathic pulmonary fibrosis
    Chakraborty, Sushmita
    Chopra, Puneet
    Ambi, Senthil V.
    Dastidar, Sunanda G.
    Ray, Abhijit
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (07) : 893 - 910
  • [10] Idiopathic pulmonary fibrosis - Pathogenesis and therapeutic approaches
    Selman, MS
    Thannickal, VJ
    Pardo, A
    Zisman, DA
    Martinez, FJ
    Lynch, JP
    DRUGS, 2004, 64 (04) : 405 - 430
12345